Are corticosteroids effective for prevention of scar formation after second-degree skin burn?

References

• Burn Incidence and Treatment in the United States: 2011 Fact Sheet. 2012. American Burn Association. http://www.ameriburn.org/resources_factsheet.php.
   Google Scholar
• Lawrence JW, Mason ST, Schomer K, Klein MB. Epidemiology and impact of scarring after burn injury: a systematic review of the literature. J Burn Care Res. 2012;33:136–146.
   PubMed Web of Science ®Google Scholar
• Ashley FL. Atrophy following cortisone injection for hypertrophic scar. Calif Med. 1973;119:65–66.
   PubMedGoogle Scholar
• Mustoe TA, Cooter RD, Gold MH, Hobbs FD, Ramelet AA, Shakespeare PG, et al. International clinical recommendations on scar management. Plast Reconstr Surg. 2002;110:560–571.
   PubMed Web of Science ®Google Scholar
• Hayashi T, Furukawa H, Oyama A, Funayama E, Saito A, Murao N, et al. A new uniform protocol of combined corticosteroid injections and ointment application reduces recurrence rates after surgical keloid/hypertrophic scar excision. Dermatol Surg. 2012;38:893–897.
   PubMed Web of Science ®Google Scholar
• Berman B, Flores F. Recurrence rates of excised keloids treated with postoperative triamcinolone acetonide injections or interferon alfa-2b injections. J Am Acad Dermatol. 1997;37:755–757.
   PubMed Web of Science ®Google Scholar
• Chowdri NA, Masarat M, Mattoo A, Darzi MA. Keloids and hypertrophic scars: results with intraoperative and serial postoperative corticosteroid injection therapy. Aust N Z J Surg. 1999;69:655–659.
   PubMedGoogle Scholar
• Kauh YC, Rouda S, Mondragon G, Tokarek R, diLeonardo M, Tuan RS, et al. Major suppression of pro-alpha1(I) type I collagen gene expression in the dermis after keloid excision and immediate intrawound injection of triamcinolone acetonide. J Am Acad Dermatol. 1997;37:586–589.
   PubMed Web of Science ®Google Scholar
• Sclafani AP, Gordon L, Chadha M, Romo T 3rd. Prevention of earlobe keloid recurrence with postoperative corticosteroid injections versus radiation therapy: a randomized, prospective study and review of the literature. Dermatol Surg. 1996;22:569–574.
   PubMed Web of Science ®Google Scholar
• Stucker FJ, Shaw GY. An approach to management of keloids. Arch Otolaryngol Head Neck Surg. 1992;118:63–67.
   PubMed Web of Science ®Google Scholar
• Shons AR, Press BH. The treatment of earlobe keloids by surgical excision and postoperative triamcinolone injection. Ann Plast Surg. 1983;10:480–482.
   Google Scholar
• Tang YW. Intra- and postoperative steroid injections for keloids and hypertrophic scars. Br J Plast Surg. 1992;45:371–373.
   PubMedGoogle Scholar
• Rosen DJ, Patel MK, Freeman K, Weiss PR. A primary protocol for the management of ear keloids: results of excision combined with intraoperative and postoperative steroid injections. Plast Reconstr Surg. 2007;120:1395–1400.
   PubMed Web of Science ®Google Scholar
• Broughton G, Janis JE, Attinger CE. Wound healing: an overview. Plast Reconstr Surg. 2006;117:1e–32e.
   PubMed Web of Science ®Google Scholar
• Shih B, Garside E, McGrouther DA, Bayat A. Molecular dissection of abnormal wound healing processes resulting in keloid disease. Wound Repair Regen. 2010;18:139–153.
   PubMed Web of Science ®Google Scholar
• Kondo T, Ishida Y. Molecular pathology of wound healing. Forensic Sci Int. 2010;203:93–98.
   PubMed Web of Science ®Google Scholar
• Profyris C, Tziotzios C, Do Vale I. Cutaneous scarring: Pathophysiology, molecular mechanisms, and scar reduction therapeutics Part I. The molecular basis of scar formation. J Am Acad Dermatol. 2012;66:1–10.
   PubMed Web of Science ®Google Scholar
• Moulin V, Larochelle S, Langlois C, Thibault I, Lopez-Vallé CA et al. Normal skin wound and hypertrophic scar myofibroblasts have differential responses to apoptotic inductors. J Cell Physiol. 2004;198:350–358.
   PubMed Web of Science ®Google Scholar
• Wolfram D, Tzankov A, Pulzl P, Piza-Katzer H. Hypertrophic scars and keloids–a review of their pathophysiology, risk factors, and therapeutic management. Dermatol Surg. 2009;35:171–181.
   PubMed Web of Science ®Google Scholar
• Gauglitz GG, Korting HC, Pavicic T, Ruzicka T, Jeschke MG. Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med. 2011;17:113–125.
   PubMed Web of Science ®Google Scholar
• Wang J, Hori K, Ding J, Huang Y, Kwan P, Ladak A. Toll-like receptors expressed by dermal fibroblasts contribute to hypertrophic scarring. J Cell Physiol. 2011;226:1265–1273.
   PubMed Web of Science ®Google Scholar
• Fassler R, Sasaki T, Timpl R, Chu ML, Werner S. Differential regulation of fibulin, tenascin-C, and nidogen expression during wound healing of normal and glucocorticoid-treated mice. Exp Cell Res. 1996;222:111–116.
   PubMed Web of Science ®Google Scholar
• Nauck M, Roth M, Tamm M, Eickelberg O, Wieland H, Stulz P. Induction of vascular endothelial growth factor by platelet-activating factor and platelet-derived growth factor is downregulated by corticosteroids. Am J Respir Cell Mol Biol. 1997;16:398–406.
   PubMed Web of Science ®Google Scholar
• Kauh YC, Rouda S, Mondragon G, Tokarek R, diLeonardo M, Tuan RS. Major suppression of pro-alpha1(I) type I collagen gene expression in the dermis after keloid excision and immediate intrawound injection of triamcinolone acetonide. J Am Acad Dermatol. 1997;37:586–589.
   PubMed Web of Science ®Google Scholar